Evidence map›Paper›PMID 38576720›Full record

ArticleRSC chemical biology2024

Cell penetration of oxadiazole-containing macrocycles.

Sungjoon Huh, Nefeli Batistatou, Jing Wang, George J Saunders, Joshua A Kritzer, Andrei K Yudin

Open access · goldAbstract read
In one paragraph

Article in RSC chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Sungjoon HuhDavenport Research Laboratories, University of Toronto 80 St. George St Toronto Ontario M5S 3H6 Canada andrei.yudin@utoronto.ca.
Nefeli BatistatouDepartment of Chemistry, Tufts University 62 Talbot Ave Medford MA 02155 USA johua.kritzer@tufts.edu.
Jing WangDepartment of Chemistry, Tufts University 62 Talbot Ave Medford MA 02155 USA johua.kritzer@tufts.edu.
George J SaundersDavenport Research Laboratories, University of Toronto 80 St. George St Toronto Ontario M5S 3H6 Canada andrei.yudin@utoronto.ca.
Joshua A KritzerDepartment of Chemistry, Tufts University 62 Talbot Ave Medford MA 02155 USA johua.kritzer@tufts.edu.ORCID https://orcid.org/0000-0003-2878-6781
Andrei K YudinDavenport Research Laboratories, University of Toronto 80 St. George St Toronto Ontario M5S 3H6 Canada andrei.yudin@utoronto.ca.ORCID https://orcid.org/0000-0003-3170-9103
Tufts University · USUniversity of Toronto · CA

Funding

Diversity Supplement for Imani McDonald - Developing Autophagy-Targeting Chimeras and Optimizing Cell Penetration of Large-Molecule TherapeuticsR35GM148407 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI Joshua A Kritzer · 2023 to 2026
$2.6M
Cell Penetration Profiling for BiotherapeuticsR01GM127585 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI KRITZER, JOSHUA A · 2018 to 2022
$1.6M
NIGMS NIH HHS R01 GM127585NIGMS NIH HHS R35 GM148407
6 · The paper itself

Abstract

Passive membrane permeability is an important property in drug discovery and biological probe design. To elucidate the cell-penetrating ability of oxadiazole-containing (Odz) peptides, we employed the Chloroalkane Penetration Assay. The present study demonstrates that Odz cyclic peptides can be highly cell-penetrant depending on the position of specific side chains and the chloroalkane tag. Solution NMR shows that Odz cyclic peptides adopt a β-turn conformation. However, despite observing high cell penetration, we observed low passive permeability in experiments with artificial membranes. These findings highlight the complexity of controlling cell penetration for conformationally sensitive macrocycles and suggest that Odz cyclic peptides may provide a framework for designing cell-penetrant cyclic peptides.

Identifiers

PMID38576720
PMCPMC10989506
OpenAlexW4390879575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.